NCT00293163
A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
Phase: Phase 4
Role: Collaborator
Start: Feb 28, 2006
Completion: Oct 31, 2006